ATS 2024 Final Program

Click on the session title to view the speakers

248

TUESDAY • MAY 21

P1204 Serum Biomarkers in Pediatric Acute Respiratory Distress Syndrome: A Prospective, Longitudinal Pilot Study P1205 Macrophage Levels in Alveolar Fluid: Signal or Noise? P1206 Energy Demand and Cholesterol Catabolism Intensify Prior to the Onset of ARDS in Surgical ICU Patients P1207 Trends in ARDS and Association Between ARDS Cause-specific Factors and Mortality: Insights From the National Inpatient Sample Database P1208 Long Term Outcomes Associated With Frailty in Hospital Survivors After Requiring Mechanical Ventilation P1209 Obesity in Critically Ill Patients Requiring Mechanical Ventilation P1210 Weaning Protocol Using Noninvasive Ventilator in Ventilator Dependent Guillain Barre Syndrome Patients P1211 Outcomes of High-flow Oxygen Therapy in Adult Medical and Post-surgical Oncology Patients: A Systematic Review and Meta-analysis P1212 Epidemiology of Acute Respiratory Failure Among Patients Hospitalized at the Veteran Affairs Health Care System Between 2012-2021 P1213 Severe Acute Respiratory Distress Syndrome in Australia and New Zealand (SAGE-ANZ): An Observational Study P1214 Is There an Inflammatory Component Present in Immersion Pulmonary Edema? Evidence From Increased Fractional Exhaled Nitric Oxide (FeNO) P1215 Is an Acute Respiratory Distress (ARDS) Diagnosis Associated With Clinical Outcomes Independent From S:F Ratios? P1216 Septic Shock as Predictor for Development of Acute Respiratory Distress Syndrome in Pulmonary Source Sepsis Patients P1217 Mechanical Ventilation and Hospital Mortality in Gram-positive Sepsis P1218 Interstitial Lung Abnormalities as a Prognostic Factor of Acute Respiratory Distress Syndrome in Sepsis

P1193 Assessing the Efficacy and Safety of Hydrocortisone, Ascorbic Acid, and Thiamine Combination Therapy for the Management of Sepsis and Septic Shock: A Systematic Review and Meta-Analysis of Randomized Controlled Trials P1194 Empiric Carbapenem Administration Against ESBL-E in Septic Shock P1195 Equity in Sepsis Care: Assessing the Impact of Sepsis Management With Mortality Rates in a Diverse Population, A Three Year Retrospective Data Analysis P1196 Improvement in Sepsis Mortality With Consistent Implementation of 3 Hour Sepsis Bundle and Healthcare Professional Education P1197 Setting Sepsis as a Priority: A Quality Improvement Project Tooptimize Sepsis Care P1198 Sepsis Bundle Compliance and Its Effect on Mortality in a Safety Net Hospital Setting P1199 Lung Epithelial Injury and Inflammation May Mediate the Relationship Between Age and Mortality in Sepsis P1200 Mass Cytometry Reveals Complex Neutrophil Heterogeneity in Patients With Septic Shock P1201 Higher Levels of Soluble LOX-1 and Oxidized LDL Are Associated With the Hypoinflammatory LCA Phenotype in Sepsis C40 ARDS AND ACUTE RESPIRATORY FAILURE: MECHANISM, RISK, AND OUTCOMES 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1203 Feasibility of a Multicenter Randomized Controlled Trial of Therapeutic Hypothermia in the Treatment of Moderate to Severe ARDS: The Cooling to Help Injured Lungs (CHILL) Trial San Diego Convention Center Area K (Hall H, Ground Level) sCLINICAL THEMATIC POSTER SESSION

ATS 2024 Conference Program • San Diego, CA